ArticleJournal of experimental & clinical cancer research : CR2023

Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids.

Eleonora Cesari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.